Comparative Efficacy of Levetiracetam for Epilepsy in School-Aged Children with Intellectual Disability and Normal Intelligence
Choosing optimal anti-seizure medication (ASM) is very important in pediatric patients with epilepsy who attend school, especially children with an intellectual disability (ID). Levetiracetam (LEV) has proven to be an effective, safe, generally well-tolerated, broad-spectrum ASM in children. In the...
Main Authors: | Ja Un Moon, Ji Yoon Han |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-10-01
|
Series: | Brain Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-3425/11/11/1452 |
Similar Items
-
Efficacy of Levetiracetam Monotherapy in Childhood Epilepsy
by: Müjgan ARSLAN, et al.
Published: (2017-04-01) -
Efficacy and safety of levetiracetam as adjunctive therapy for refractory focal epilepsy
by: Maria Luiza Giraldes de MANREZA, et al.
Published: (2021-06-01) -
Levetiracetam – epilepsy treatment, pharmacokinetics, mechanism of action, interaction and toxicity
by: Piotr Kozłowski, et al.
Published: (2015-04-01) -
Levetiracetam – epilepsy treatment, pharmacokinetics, mechanism of action, interaction and toxicity
by: Piotr Kozłowski, et al.
Published: (2015-04-01) -
Levetiracetam for epilepsy: an evidence map of efficacy, safety and economic profiles
by: Yi ZM, et al.
Published: (2018-12-01)